Epigenetic mechanisms in virus-induced tumorigenesis

Clinical Epigenetics

Volumn 2, Issue 2, 2011, Pages 233-247

  Poreba, Elzbieta ^a   Broniarczyk, Justyna Karolina ^a   Gozdzicka Jozefiak, Anna ^a  

^a ADAM MICKIEWICZ UNIVERSITY   (Poland)

Author keywords

DNA methylation; Epigenetics; Histone modification; Human cancer; Oncogenetic virus

Indexed keywords

E1A PROTEIN; E1B PROTEIN; GENOMIC DNA; HEPATITIS B VIRUS X PROTEIN; PROTEIN E2; PROTEIN E6; PROTEIN E7; PROTEIN LANA; PROTEIN LMP1; TAX PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADENOVIRUS; BINDING AFFINITY; BINDING SITE; CANCER RISK; DISEASE ACTIVITY; DISEASE ASSOCIATION; DNA METHYLATION; DNA VIRUS; EPIGENETICS; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENE SILENCING; HEPATITIS B VIRUS; HISTONE MODIFICATION; HUMAN; HUMAN HERPESVIRUS 8; HUMAN T CELL LEUKEMIA VIRUS 1; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; RISK ASSESSMENT; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS CARCINOGENESIS; VIRUS CELL INTERACTION; VIRUS GENE; WART VIRUS;

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; HUMAN PAPILLOMAVIRUS; RNA VIRUSES;

EID: 84856239100     PISSN: 18687075     EISSN: 18687083     Source Type: Journal    
DOI: 10.1007/s13148-011-0026-6     Document Type: Review

References (166)

1. Anderton JA, Bose S, Vockerodt M, Vrzalikova K, Wei W, Kuo M, Helin K, Christensen J, Rowe M, Murray PG, Woodman CB (2011) The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's lymphoma. Oncogene. doi:10.1038/onc.2010.579
2. Araujo AQ, Silva MT (2006) The HTLV-1 neurological complex. Lancet Neurol 5(12):1068-1076. doi:10.1016/S1474-4422(06)70628-7 (Pubitemid 44709983)
3. Areste' C, Blackbourn DJ (2009) Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus. Trends Microbiol 17:119-129. doi:10.1016/j.tim.2008.12.001
4. Arisawa K, Soda M, Endo S, Kurokawa K, Katamine S, Shimokawa I, Koba T, Takahashi T, Saito H, Doi H, Shirahama S (2000) Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan. Int J Cancer 85(3):319-324. doi:10.1002/(SICI)1097-0215 (20000201)85:3 (Pubitemid 30030402)
5. Arvanitakis L, Yaseen N, Sharma S (1995) Latent membrane protein-1 induces cyclin D2 expression, pRb hyperphosphorylation, and loss of TGF-beta 1-mediated growth inhibition in EBV-positive B cells. J Immunol 155(3):1047-1056
6. Avvakumov N, Torchia J, Mymryk JS (2003) Interaction of the HPV E7 proteins with the pCAF acetyltransferase. Oncogene 22 (25):3833-3841. doi:10.1038/sj.onc.1206562 (Pubitemid 36819656)
7. Badal V, Chuang LS, Tan EH, Badal S, Villa LL, Wheeler CM, Li BF, Bernard HU (2003) CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77(11):6227-6234. doi:10.1128/JVI.77.11. 6227-6234.2003 (Pubitemid 36588393)
8. Badal S, Badal V, Calleja-Macias IE, Kalantari M, Chuang LS, Li BF, Bernard HU (2004) The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324 (2):483-492. doi:10.1016/j.virol.2004.04. 002 (Pubitemid 38797864)
9. Beck J, Nassal M (2007) Hepatitis B virus replication. World J Gastroenterol 13:48-64 (Pubitemid 46165462)
10. Bhattacharjee B, Sengupta S (2006) CpG methylation of HPV 16 LCR at E2 binding site proximal to P97 is associated with cervical cancer in presence of intact E2. Virology 354(2):280-285. doi:10.1016/j.virol.2006.06.018 (Pubitemid 44527961)
11. Bhende PM, Seaman WT, Delecluse HJ, Kenney SC (2005) BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol 79:7338-7348. doi:10.1128/JVI.79.12.7338-7348.2005 (Pubitemid 40756769)
12. Biancotto C, Frigé G, Minucci S (2010) Histone modification therapy of cancer. Adv Genet 70:341-386. doi:10.1016/B978-0-12-380866-0.60013-7
13. Blackford AN, Grand RJ (2009) Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation. J Virol 83(9):4000-4012. doi:10.1128/JVI.02417-08
14. Bornkamm GW (2009) Epstein-Barr virus and the pathogenesis of Burkitt's lymphoma: more questions than answers. Int J Cancer 124:1745-1755. doi:10.1002/ijc.24223
15. Brandsma JL, Sun Y, Lizardi PM, Tuck DP, Zelterman D, Haines GK 3rd, Martel M, Harigopal M, Schofield K, Neapolitano M (2009) Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy. Virology 389(1-2):100-107. doi:10.1016/j.virol.2009.03.029
16. Brown KD, Hostager BS, Bishop GA (2001) Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). J Exp Med 193(8):943-954. doi:10.1084/jem.193.8.943 (Pubitemid 32525867)
17. Burgers WA, Blanchon L, Pradhan S, de Launoit Y, Kouzarides T, Fuks F (2006) Viral oncoproteins target the DNA methyltransferases. Oncogene 26(11):1650-1655. doi:10.1038/sj. onc.1209950
18. Burgers WA, Blanchon L, Pradhan S, de Launoit Y, Kouzarides T, Fuks F (2007) Viral oncoproteins target the DNA methyltransferases. Oncogene 26(11):1650. doi:10.1038/sj.onc.1209950 (Pubitemid 46398736)
19. Butel JS (2000) Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcinogenesis 21:405-426. doi:10.1093/carcin/21. 3.405 (Pubitemid 30137926)
20. Cai X, Schäfer A, Lu S, Bilello JP, Desrosiers RC, Edwards R, Raab-Traub N, Cullen BR (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2:e23. doi:10.1371/journal. ppat.0020023
21. Chang Y, Lee HH, Chen YT, Lu J, Wu SY, Chen CW, Takada K, Tsai CH (2006) Induction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta. J Virol 80:7748-7755. doi:10.1128/JVI.02608-05 (Pubitemid 44092594)
22. Chi P, Allis CD, Wang GG (2010) Covalent histone modifications- miswritten, misinterpreted and mis-erased in human cancers. Nat Rev Cancer 10(7):457-469. doi:10.1038/nrc2876
23. Ciuffo G (1907) Innesto positivo con filtrato di verruca volgare. Giorn Ital Mal Venereol 48:12-17
24. Cohen Y, Singer G, Lavie O, Dong SM, Beller U, Sidransky D (2003) The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix. Clin Cancer Res 9 (8):2981-2984 (Pubitemid 36993256)
25. Cougot D, Neuveut C, BuendiaMA(2005)HBVinduced carcinogenesis. J Clin Virol 34:S75-S78. doi:10.1016/S1386-6532(05)80014-9 (Pubitemid 43197752)
26. Cougot D, Wu Y, Cairo S, Caramel J, Renard CA, Lévy L, Buendia MA, Neuveut C (2007) The hepatitis B virus X protein functionally interacts with CREB-binding protein/p300 in the regulation of CREB-mediated transcription. J Biol Chem 282:4277-4287. doi:10.1074/jbc.M606774200 (Pubitemid 47100918)
27. Countryman JK, Gradoville L, Miller G (2008) Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J Virol 82:4706-4719. doi:10.1128/JVI.00116-08 (Pubitemid 351657033)
28. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1):17-27. doi:10.1016/j.virol. 2004.03.033 (Pubitemid 38737395)
29. Di Bartolo DL, Cannon M, Liu YF, Renne R, Chadburn A, Boshoff C, Cesarman E (2008) KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood 111:4731-4740. doi:10.1182/blood-2007-09- 110544
30. Dickerson SJ, Xing Y, Robinson AR, Seaman WT, Gruffat H, Kenney SC (2009) Methylation-dependent binding of the Epstein-Barr virus BZLF1 protein to viral promoters. PLoS Pathog 5: e1000356. doi:10.1371/journal.ppat.1000356
31. Doerfler W (1991a) Abortive infection and malignant transformation by adenoviruses: integration of viral DNA and control of viral gene expression by specific patterns of DNA methylation. Adv Virus Res 39:89-128
32. Doerfler W (1991b) Patterns of DNA methylation-evolutionary vestiges of foreign DNA inactivation as a host defense mechanism. A proposal. Biol Chem Hoppe Seyler 372:557-564
33. Doerfler W (1996) A new concept in (adenoviral) oncogenesis: integration of foreign DNA and its consequences. Biochim Biophys Acta 1288(2):F79-F99. doi:10.1016/0304-419X(96)00024-8 (Pubitemid 26335493)
34. Doerfler W (2009) Epigenetic mechanisms in human adenovirus type 12 oncogenesis. Semin Cancer Biol 19(3):136-143. doi:10.1016/j.semcancer.2009.02. 009
35. Doorbar J (2005) The papillomavirus life cycle. J Clin Virol 32(Suppl 1):S7-S15. doi:10.1016/j.jcv.2004.12.006 (Pubitemid 40332584)
36. Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci Lond 110(5):525-541. doi:10.1042/CS20050369 (Pubitemid 43736116)
37. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM (2003) Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67:175-212. doi:10.1128/MMBR.67.2.175-212.2003 (Pubitemid 36693471)
38. Endter C, Dobner T (2004) Cell transformation by human adenoviruses. Curr Top Microbiol Immunol 273:163-214 (Pubitemid 37203634)
39. Esteller M (2006) Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 94(2):179-183. doi:10.1038/sj.bjc.6602918 (Pubitemid 43151531)
40. Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8(4):286-298. doi:10.1038/nrg2005 (Pubitemid 46439286)
41. Fejer G, Koroknai A, Banati F, Györy I, Salamon D, Wolf H, Niller HH, Minarovits J (2008) Latency type-specific distribution of epigenetic marks at the alternative promoters Cp and Qp of Epstein-Barr virus. J Gen Virol 89:1364-1370. doi:10.1099/vir.0.83594-0
42. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100. doi:10.1126/science.1152586 (Pubitemid 351300792)
43. Fernandez AF, Esteller M (2010) Viral epigenomes in human tumorigenesis. Oncogene 29(10):1405-1420. doi:10.1038/onc.2009.517
44. Fernandez AF, Rosales C, Lopez-Nieva P, Graña O, Ballestar E, Ropero S, Espada J, Melo SA, Lujambio A, Fraga MF, Pino I, Javierre B, Carmona FJ, Acquadro F, Steenbergen RD, Snijders PJ, Meijer CJ, Pineau P, Dejean A, Lloveras B, Capella G, Quer J, Buti M, Esteban JI, Allende H, Rodriguez-Frias F, Castellsague X, Minarovits J, Ponce J, Capello D, Gaidano G, Cigudosa JC, Gomez-Lopez G, Pisano DG, Valencia A, Piris MA, Bosch FX, Cahir-McFarland E, Kieff E, Esteller M (2009) The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer. Genome Res 19(3):438-451. doi:10.1101/gr.083550.108
45. Ferrari R, Pellegrini M, Horwitz GA, Xie W, Berk AJ, Kurdistani SK (2008) Epigenetic reprogramming by adenovirus e1a. Science 321(5892):1086-1088. doi:10.1126/science.1155546
46. Ferrari R, Berk AJ, Kurdistani SK (2009) Viral manipulation of the host epigenome for oncogenic transformation. Nat Rev Genet 10:290-294. doi:10.1038/nrg2539
47. Flanagan JM (2007) Host epigenetic modifications by oncogenic viruses. Br J Cancer 96:183-188. doi:10.1038/sj.bjc.6603516 (Pubitemid 46160618)
48. Fuchs M, Gerber J, Drapkin R, Sif S, Ikura T, Ogryzko V, Lane WS, Nakatani Y, Livingston DM (2001) The p400 complex is an essential E1A transformation target. Cell 106(3):297-307. doi:10.1016/S0092-8674(01)00450-0 (Pubitemid 32772614)
49. Fukayama M, Hino R, Uozaki H (2008) Epstein-Barr virus and gastric carcinoma: virus-host interactions leading to carcinoma. Cancer Sci 99:1726-1733. doi:10.1111/j.1349-7006.2008.00888.x
50. Garnett CT, Talekar G, Mahr JA, Huang W, Zhang Y, Ornelles DA, Gooding LR (2009) Latent species C adenoviruses in human tonsil tissues. J Virol 83(6):2417-2428. doi:10.1128/JVI.02392-08
51. Gatza ML, Chandhasin C, Ducu RI, Marriott SJ (2005) Impact of transforming viruses on cellular mutagenesis, genome stability, and cellular transformation. Environ Mol Mutagen 45(2-3):304-325. doi:10.1002/em.20088
52. Gerle B, Koroknai A, Fejer G, Bakos A, Banati F, Szenthe K, Wolf H, Niller HH, Minarovits J, Salamon D (2007) Acetylated histone H3 and H4 mark the upregulated LMP2A promoter of Epstein-Barr virus in lymphoid cells. J Virol 81(23):13242-13247. doi:10.1128/JVI.01396-07 (Pubitemid 350156962)
53. Goel A, Li M-S, Nagasaka T, Shin SK, Fuerst F, Ricciardiello L et al (2006) Association of JC virus T-antigen expression with the methylator phenotype in sporadic colorectal cancers. Gastroenterology 130:1950-1961. doi:10.1053/j.gastro.2006.02.061 (Pubitemid 43816967)
54. Gottwein E, Cullen BR (2008) Viral and cellular MicroRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3:375-387. doi:10.1016/j.chom.2008.05.002 (Pubitemid 351773098)
55. Graham FL, Rowe DT, McKinnon R, Bacchetti S, Ruben M, Branton PE (1984) Transformation by human adenoviruses. J Cell Physiol Suppl 3:151-163 (Pubitemid 14099983)
56. Gurtsevitch VE (2008) Human oncogenic viruses: hepatitis B and hepatitis C viruses and their role in hepatocarcinogenesis. Biochem Mosc 73:504-513. doi:10.1134/S0006297908050039 (Pubitemid 351775074)
57. Gwack Y, Hwang S, Byun H, Lim C, Kim JW, Choi EJ, Choe J (2001) Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol 75(13):6245-6248. doi:10.1128/JVI.75.13.6245-6248.2001 (Pubitemid 32553160)
58. Gwack Y, Hwang S, Lim C, Won YS, Lee CH, Choe J (2002) Kaposi's sarcoma-associated herpesvirus open reading frame 50 stimulates the transcriptional activity of STAT3. J Biol Chem 277 (8):6438-6442. doi:10.1074/jbc.M108289200 (Pubitemid 34968439)
59. Heather J, Flower K, Isaac S, Sinclair AJ (2009) The Epstein-Barr virus lytic cycle activator Zta interacts with methylated ZRE in the promoter of host target gene egr1. J Gen Virol 90:1450-1454. doi:10.1099/vir.0.007922-0
60. Hino R, Uozaki H, Murakami N, Ushiku T, Shinozaki A, Ishikawa S, Morikawa T, Nakaya T, Sakatani T, Takada K, Fukayama M (2009) Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma. Cancer Res 69:2766-2774. doi:10.1158/0008-5472.CAN-08-3070
61. Holland D, Hoppe-Seyler K, Schuller B, Lohrey C, Maroldt J, Dürst M, Hoppe-Seyler F (2008) Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res 68 (23):9964-9972. doi:10.1158/0008-5472.CAN-08-1134
62. Horwitz GA, Zhang K, McBrian MA, Grunstein M, Kurdistani SK, Berk AJ (2008) Adenovirus small e1a alters global patterns of histone modification. Science 321(5892):1084-1085. doi:10.1126/science.1155544
63. Hublarova P, Hrstka R, Rotterova P, Rotter L, Coupkova M, Badal V, Nenutil R, Vojtesek B (2009) Prediction of human papillomavirus 16 e6 gene expression and cervical intraepithelial neoplasia progression by methylation status. Int J Gynecol Cancer 19:321-325
64. Hwang S, Gwack Y, Byun H, Lim C, Choe J (2001) The Kaposi's sarcoma-associated herpesvirus K8 protein interacts with CREBbinding protein (CBP) and represses CBP-mediated transcription. J Virol 75(19):9509-9516. doi:10.1128/JVI.75.19.9509-9516.2001 (Pubitemid 32851953)
65. Ivanova T, Petrenko A, Gritsko T, Vinokourova S, Eshilev E, Kobzeva V, Kisseljov F, Kisseljova N (2002) Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer. BMC Cancer 21:2-4. doi:10.1186/1471- 2407-2-4 (Pubitemid 38846515)
66. Iyer NG, Ozdag H, Caldas C (2004) p300/CBP and cancer. Oncogene 23:4225-4231. doi:10.1038/sj.onc.1207118 (Pubitemid 38758588)
67. Javier RT, Butel JS (2008) The history of tumor virology. Cancer Res 68:7693-7706. doi:10.1158/0008-5472.CAN-08-3301
68. Jiang M, Abend JR, Johnson SF, Imperiale MJ (2009) The role of polyomaviruses in human disease. Virology 384:266-273. doi:10.1016/j.virol.2008. 09.027
69. Jones PA, Baylin SB (2002) The fundamental role of epigenetic events in cancer. Nat Rev Genet 3:415-428 (Pubitemid 34587077)
70. Jung JK, Arora P, Pagano JS, Jang KL (2007) Expression of DNA methyltransferase 1 is activated by hepatitis B virus X protein via a regulatory circuit involving the p16INK4a-cyclin D1-CDK 4/6-pRb-E2F1 pathway. Cancer Res 67:5771-5778. doi:10.1158/0008-5472.CAN-07-0529 (Pubitemid 46985010)
71. Kalantari M, Calleja-Macias IE, Tewari D, Hagmar B, Lie K, Barrera-Saldana HA, Wiley DJ, Bernard HU (2004) Conserved methylation patterns of human papillomavirus type 16 DNA in asymptomatic infection and cervical neoplasia. J Virol 78 (23):12762-12772. doi:10.1128/JVI.78.23.12762-12772.2004 (Pubitemid 39507784)
72. Kamoi K, Yamamoto K, Misawa A, Miyake A, Ishida T, Tanaka Y, Mochizuki M, Watanabe T (2006) SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR. Retrovirology 3:5. doi:10.1186/1742-4690-3-5 (Pubitemid 43264243)
73. Kilger E, Kieser A, Baumann M, Hammerschmidt W (1998) Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J 17(6):1700-1709. doi:10.1093/emboj/17.6.1700 (Pubitemid 28119123)
74. Kim K, Garner-Hamrick PA, Fisher C, Lee D, Lambert PF (2003) Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77 (23):12450-12459. doi:10.1128/JVI.77.23.12450- 12459.2003 (Pubitemid 37430642)
75. Klein E, Kis LL, Klein G (2007) Epstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions. Oncogene 26:1297-1305. doi:10.1038/sj. onc.1210240 (Pubitemid 46328467)
76. Knight JS, Lan K, Subramanian C, Robertson ES (2003) Epstein-Barr virus nuclear antigen 3C recruits histone deacetylase activity and associates with the corepressors mSin3A and NCoR in human Bcell lines. J Virol 77(7):4261-4272. doi:10.1128/JVI.77.7.4261-4272.2003 (Pubitemid 36350964)
77. Koiwa T, Hamano-Usami A, Ishida T, Okayama A, Yamaguchi K, Kamihira S, Watanabe T (2002) 5′-Long terminal repeat-selective CpG methylation of latent human T-cell leukemia virus type 1 provirus in vitro and in vivo. J Virol 76(18):9389-9397. doi:10.1128/JVI.76.18.9389-9397.2002 (Pubitemid 34919896)
78. Kosulin K, Haberler C, Hainfellner JA, Amann G, Lang S, Lion T (2007) Investigation of adenovirus occurrence in pediatric tumor entities. J Virol 81(14):7629-7635. doi:10.1128/JVI.00355-07 (Pubitemid 47047848)
79. Kulis M, Esteller M (2010) DNA methylation and cancer. Adv Genet 70:27-56. doi:10.1016/B978-0-12-380866-0.60002-2
80. Kuzmichev A, Margueron R, Vaquero A, Preissner TS, Scher M, Kirmizis A, Ouyang X, Brockdorff N, Abate-Shen C, Farnham P, Reinberg D (2005) Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation. Proc Natl Acad Sci USA 102(6):1859-1864. doi:10.1073/pnas.0409875102 (Pubitemid 40261977)
81. Kwong J, Lo KW, To KF, Teo PM, Johnson PJ, Huang DP (2002) Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. Clin Cancer Res 8(1):131-137 (Pubitemid 34101468)
82. Lang SE, Hearing P (2003) The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex. Oncogene 22:2836-2841. doi:10.1038/sj.onc.1206376 (Pubitemid 36609597)
83. Li H, Minarovits J (2003) Host cell-dependent expression of latent Epstein-Barr virus genomes: regulation by DNA methylation. Adv Cancer Res 89:133-156. doi:10.1016/S0065-230X(03)01004-2 (Pubitemid 41184281)
84. Li M, Damania B, Alvarez X, Ogryzko V, Ozato K, Jung JU (2000) Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol Cell Biol 20:8254-8263. doi:10.1128/MCB.20.21.8254-8263.2000
85. Lim C, Gwack Y, Hwang S, Kim S, Choe J (2001) The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 276 (33):31016-31022. doi:10.1074/jbc.M102431200
86. Liu SS, Leung RC, Chan KY, Chiu PM, Cheung AN, Tam KF, Ng TY, Wong LC, Ngan HY (2004) p73 Expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy. Clin Cancer Res 10:3309-3316. doi:10.1158/1078-0432.CCR-03-0119 (Pubitemid 38685435)
87. Lo KW, Kwong J, Hui AB, Chan SY, To KF, Chan AS, Chow LS, Teo PM, Johnson PJ, Huang DP (2001) High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. Cancer Res 61(10):3877-3881 (Pubitemid 32720944)
88. Lo KW, Tsang YS, Kwong J, To KF, Teo PM, Huang DP (2002) Promoter hypermethylation of the EDNRB gene in nasopharyngeal carcinoma. Int J Cancer 98(5):651-655. doi:10.1002/ijc.10271 (Pubitemid 34225614)
89. Longworth MS, Wilson R, Laimins LA (2005) HPV31 E7 facilitates replication by activating E2F2 transcription through its interaction with HDACs. EMBO J 24(10):1821-1823. doi:10.1038/sj.emboj.7600651 (Pubitemid 40769501)
90. Lu F, Day L, Gao SJ, Lieberman PM (2006) Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. J Virol 80:5273-5282. doi:10.1128/JVI.02541-05
91. Martin ME, Berk AJ (1998) Adenovirus E1B 55K represses p53 activation in vitro. J Virol 72(4):3146-3154 (Pubitemid 28175557)
92. Martin D, Gutkind JS (2008) Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene Suppl 2:S31-S42. doi:10.1038/onc.2009.351
93. Martinez-Garcia E, Licht JD (2010) Deregulation of H3K27 methylation in cancer. Nat Genet 42(2):100-101. doi:10.1038/ng0210-100
94. Matsuoka M, Jeang KT (2007) Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer 7:270-280. doi:10.1038/nrc2111 (Pubitemid 46480972)
95. McCabe MT, Davis JN, Day ML (2005) Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res 9:3624-3632. doi:10.1158/0008-5472.CAN-04- 2158 (Pubitemid 40616339)
96. McCabe MT, Low JA, Imperiale MJ, Day ML (2006) Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb//E2F pathway. Oncogene 25:2727-2735. doi:10.1038/sj.onc.1209266
97. McLaughlin-Drubin ME, Munger K (2008) Viruses associated with human cancer. Biochim Biophys Acta 1782(3):127-150. doi:10.1016/j.bbadis.2007.12.005
98. McLaughlin-Drubin ME, Crum CP, Münger K (2011) Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci USA 108(5):2130-2135. doi:10.1073/pnas.1009933108
99. Moens U (2009) Silencing viral microRNA as a novel antiviral therapy? J Biomed Biotechnol 2009:419539. doi:10.1155/2009/419539
100. Mosialos G, Birkenbach M, Yalamanchili R, VanArsdale T, Ware C, Kieff E (1995) The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80(3):389-399. doi:10.1016/0092-8674(95) 90489-1
101. Nair V, Zavolan M (2006) Virus-encoded microRNAs: novel regulators of gene expression. Trends Microbiol 14:169-175. doi:10.1016/j.tim.2006.02.007
102. Nakashima R, Fujita M, Enomoto T, Haba T, Yoshino K, Wada H, Kurachi H, Sasaki M, Wakasa K, Inoue M, Buzard G, Murata Y (1999a) Alteration of p16 and p15 genes in human uterine tumours. Br J Cancer 80(3-4):458-467. doi:10.1038/sj.bjc.6690379 (Pubitemid 29213201)
103. Nakashima R, Song H, Enomoto T, Murata Y, McClaid MR, Casto BC, Weghorst CM (1999b) Genetic alterations in the transforming growth factor receptor complex in sporadic endometrial carcinoma. Gene Expr 8(5-6):341-352 (Pubitemid 30637492)
104. Narayan G, Arias-Pulido H, Koul S, Vargas H, Zhang FF, Villella J, Schneider A, Terry MB, Mansukhani M, Murty VV (2003) Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer 2:24. doi:10.1186/1476-4598-2- 24 (Pubitemid 38751473)
105. Nevels M, Täuber B, Spruss T, Wolf H, Dobner T (2001) "Hit-andrun" transformation by adenovirus oncogenes. J Virol 75 (7):3089-3094. doi:10.1128/JVI.75.7.3089-3094.2001 (Pubitemid 32225872)
106. Niemhom S, Kitazawa S, Kitazawa R, Maeda S, Leopairat J (2008) Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Cancer Detect Prev 32:127-134. doi:10.1016/j.cdp.2008.05.005
107. Niller HH, Wolf H, Minarovits J (2008) Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases. Autoimmunity 41:298-328. doi:10.1080/08916930802024772 (Pubitemid 351593860)
108. Nuovo GJ, Plaia TW, Belinsky SA, Baylin SB, Herman JG (1999) In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis. Proc Natl Acad Sci USA 96(22):12754-12759. doi:10.1073/pnas.96.22.12754 (Pubitemid 29513575)
109. Oliveira D (2007) DNAviruses in human cancer: an integrated overview on fundamental mechanisms of viral carcinogenesis. Cancer Lett 18;247(2):182-196. doi:10.1016/j.canlet.2006.05.010 (Pubitemid 46240621)
110. O'Shea CC (2005) Viruses-seeking and destroying the tumor program. Oncogene 24(52):7640-7655. doi:10.1038/sj. onc.1209047
111. Pai S, O'Sullivan B, Abdul-Jabbar I, Peng J, Connoly G, Khanna R, Thomas R (2007) Nasopharyngeal carcinoma-associated Epstein-Barr virus-encoded oncogene latent membrane protein 1 potentiates regulatory T-cell function. Immunol Cell Biol 85 (5):370-377. doi:10.1038/sj.icb.7100046 (Pubitemid 47035607)
112. Pantry SN, Medveczky PG (2009) Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication. Semin Cancer Biol 19:153-157. doi:10.1016/j.semcancer.2009.02.010
113. Park IY, Sohn BH, Yu E, Suh DJ, Chung YH, Lee JH, Surzycki SJ, Lee YI (2007a) Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132:1476-1494. doi:10.1053/j.gastro.2007.01.034 (Pubitemid 46627570)
114. Park JH, Jeon JP, Shim SM, Nam HY, Kim JW, Han BG, Lee S (2007b) Wp specific methylation of highly proliferated LCLs. Biochem Biophys Res Commun 358:513-520. doi:10.1016/j.bbrc.2007.04.169 (Pubitemid 46805045)
115. Patel D, Huang SM, Baglia LA, McCance DJ (1999) The E6 protein of human papillomavirus type 16 binds to and inhibits coactivation by CBP and p300. EMBO J 18(18):5061-5072. doi:10.1093/emboj/18.18.5061 (Pubitemid 29443808)
116. Paulson EJ, Speck SH (1999) Differential methylation of Epstein-Barr virus latency promoters facilitates viral persistence in healthy seropositive individuals. J Virol 73:9959-9968
117. Pfeffer S, Zavolan M, Grässer FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T (2004) Identification of virus-encoded MicroRNAs. Science 304:734-736. doi:10.1126/science.1096781 (Pubitemid 38560879)
118. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL (2005) Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24(39):6058-6068. doi:10.1038/sj. onc.1208968 (Pubitemid 43086123)
119. Remus R, Kämmer C, Heller H, Schmitz B, Schell G, Doerfler W (1999) Insertion of foreign DNA into an established mammalian genome can alter the methylation of cellular DNA sequences. J Virol 73(2):1010-1022 (Pubitemid 29036752)
120. Robertson KD (2001) DNA methylation, methyltransferases, and cancer. Oncogene 20:3139-3155. doi:10.1038/sj.onc.1204341 (Pubitemid 32553570)
121. Robertson KD, Ambinder RF (1997) Methylation of the Epstein-Barr virus genome in normal lymphocytes. Blood 90:4480-4484 (Pubitemid 27508453)
122. Ropero S, Esteller M (2007) The role of histone deacetylases (HDACs) in human cancer. Mol Oncol 1(1):19-25. doi:10.1016/j.molonc.2007.01.001 (Pubitemid 46776612)
123. Russell WC (2009) Adenoviruses: update on structure and function. J Gen Virol 90(Pt 1):1-20. doi:10.1099/vir.0.003087-0
124. Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, Baker HV, Renne R (2007) Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 3:e65. doi:10.1371/journal.ppat.0030065 (Pubitemid 46827946)
125. Seeger C, Mason WS (2000) Hepatitis B virus biology. Microbiol Mol Biol Rev 64:51-68. doi:10.1128/MMBR.64.1.51-68.2000 (Pubitemid 30143840)
126. Shamay M, Krithivas A, Zhang J, Hayward SD (2006) Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA. Proc Natl Acad Sci 103:14554-14559. doi:10.1073/pnas.0604469103 (Pubitemid 44484788)
127. Shivapurkar N, Toyooka S, Toyooka KO, Reddy J, Miyajima K, Suzuki M, Shigematsu H, Takahashi T, Parikh G, Pass HI, Chaudhary PM, Gazdar AF (2004) Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types. Int J Cancer 109(5):786-792. doi:10.1002/ijc.20041 (Pubitemid 38405630)
128. Shon JK, Shon BH, Park IY, Lee SU, Fa L, Chang KY, Shin JH, Lee YI (2009) Hepatitis B virus-X protein recruits histone deacetylase 1 to repress insulin-like growth factor binding protein 3 transcription. Virus Res 139:14-21. doi:10.1016/j.virusres.2008.09.006
129. Simon JA, Lange CA (2008) Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 647(1-2):21-29. doi:10.1016/j.mrfmmm.2008.07.010
130. Soria C, Estermann FE, Espantman KC, O'Shea CC (2010) Heterochromatin silencing of p53 target genes by a small viral protein. Nature 466(7310):1076-1081. doi:10.1038/nature09307
131. Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G (1998) A viral gene that activates lytic cycle expression of Kaposi's sarcomaassociated herpesvirus. Proc Natl Acad Sci 95:10866-10871. doi:10.1073/pnas.95.18.10866 (Pubitemid 28413160)
132. Suzuki MM, Bird A (2008) DNA methylation landscapes: provocative insights from epigenomics. Nat Rev Genet 9(6):465-476. doi:10.1038/nrg2341 (Pubitemid 351693975)
133. Szalmás A, Kónya J (2009) Epigenetic alterations in cervical carcinogenesis. Semin Cancer Biol 19(3):144-152. doi:10.1016/j. semcancer.2009.02.011
134. Takacs M, Banati F, Koroknai A, Segesdi J, Salamon D, Wolf H, Niller HH, Minarovits J (2010) Epigenetic regulation of latent Epstein-Barr virus promoters. Biochim Biophys Acta 1799(3-4):228-235. doi:10.1016/j.bbagrm.2009.10. 005
135. Takeda S, Maeda M, Morikawa S, Taniguchi Y, Yasunaga J, Nosaka K, Tanaka Y, Matsuoka M (2004) Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells. Int J Cancer 109(4):559-567. doi:10.1002/ijc.20007 (Pubitemid 38339647)
136. Taniguchi Y, Nosaka K, Yasunaga J, Maeda M, Mueller N, Okayama A, Matsuoka M (2005) Silencing of human T-cell leukemia virus type I gene transcription by epigenetic mechanisms. Retrovirology 2:64. doi:10.1186/1742- 4690-2-64 (Pubitemid 41631201)
137. Tao Q, Robertson KD (2003) Stealth technology: how Epstein-Barr virus utilizes DNA methylation to cloak itself from immune detection. Clin Immunol 109:53-63. doi:10.1016/S1521-6616 (03)00198-0 (Pubitemid 37324742)
138. Tao Q, Robertson KD, Manns A, Hildesheim A, Ambinder RF (1998) The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive. J Virol 72:7075-7083 (Pubitemid 28377835)
139. Täuber B, Dobner T (2001) Adenovirus early E4 genes in viral oncogenesis. Oncogene 20(54):7847-7854. doi:10.1038/sj. onc.1204914 (Pubitemid 33135311)
140. Thain A, Jenkins O, Clarke AR, Gaston K (1996) CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol 70(10):7233-7235 (Pubitemid 26307443)
141. Tong JH, Tsang RK, Lo KW, Woo JK, Kwong J, Chan MW, Chang AR, van Hasselt CA, Huang DP, To KF (2002) Quantitative Epstein-Barr virus DNA analysis and detection of gene promoter hypermethylation in nasopharyngeal (NP) brushing samples from patients with NP carcinoma. Clin Cancer Res 8(8):2612-2619 (Pubitemid 34856348)
142. Tsai CN, Tsai CL, Tse KP, Chang HY, Chang YS (2002) The Epstein-Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases. Proc Natl Acad Sci USA 99 (15):10084-10089. doi:10.1073/pnas.152059399 (Pubitemid 34831176)
143. Turan T, Kalantari M, Calleja-Macias IE, Cubie HA, Cuschieri K, Villa LL, Skomedal H, Barrera-Saldaña HA, Bernard HU (2006) Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology 349(1):175-183. doi:10.1016/j.virol.2005.12.033
144. Turan T, Kalantari M, Cuschieri K, Cubie HA, Skomedal H, Bernard HU (2007) High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia. Virology 361(1):185-193. doi:10.1016/j.virol.2006.11.010 (Pubitemid 46553810)
145. Van Tine BA, Dao LD, Wu SY, Sonbuchner TM, Lin BY, Zou N, Chiang CM, Broker TR, Chow LT (2004) Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci USA 101 (12):4030-4035. doi:10.1073/pnas.0306848101 (Pubitemid 38405878)
146. Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF (2001) Aberrant methylation during cervical carcinogenesis. Clin Cancer Res 7:584-589 (Pubitemid 32707982)
147. Wang L, Grossman SR, Kieff E (2000) Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases inactivation of the LMP1 promoter. Proc Natl Acad Sci USA 97:430-435. doi:10.1073/pnas.97.1.430 (Pubitemid 30055848)
148. Whitby D (2009) Searching for targets of viral microRNAs. Nat Genet 41:7-8. doi:10.1038/ng0109-7
149. Widschwendter A, Gattringer C, Ivarsson L, Fiegl H, Schneitter A, Ramoni A, Müller HM, Wiedemair A, Jerabek S, Müller-Holzner E, Goebel G, Marth C, Widschwendter M (2004) Analysis of aberrant DNA methylation and human papillomavirus DNA in cervicovaginal specimens to detect invasive cervical cancer and its precursors. Clin Cancer Res 10(10):3396-3400. doi:10.1158/1078-0432.CCR-03-0143 (Pubitemid 38685445)
150. Wiley DJ, Huh J, Rao JY, Chang C, Goetz M, Poulter M, Masongsong E, Chang CI, Bernard HU (2005) Methylation of human papillomavirus genomes in cells of anal epithelia of HIVinfected men. J Acquir Immune Defic Syndr 39(2):143-151 (Pubitemid 40741111)
151. Williams H, Crawford DH (2006) Epstein-Barr virus: the impact of scientific advances on clinical practice. Blood 107:862-869. doi:10.1182/blood-2005-07-2702 (Pubitemid 43156280)
152. Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7 (1):11-22. doi:10.1038/nrc2050 (Pubitemid 46020844)
153. Yokosuka O, Arai M (2006) Molecular biology of hepatitis B virus: effect of nucleotide substitutions on the clinical features of chronic hepatitis B. Med Mol Morphol 39:113-120. doi:10.1007/s00795-006-0328-5 (Pubitemid 44440459)
154. Yoshida M (2001) Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol 19:475-496. doi:10.1146/annurev.immunol. 19.1.475 (Pubitemid 32368043)
155. Yoshida M (2005) Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24(39):5931-5937. doi:10.1038/sj.onc.1208981 (Pubitemid 43086111)
156. Yoshioka M, Kikuta H, Ishiguro N, Endo R, Kobayashi K (2003) Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome. J Med Virol 70:410-419. doi:10.1002/jmv.10411 (Pubitemid 36638055)
157. Young LS, Rickinson AB (2004) Epstein-Barr virus: 40 years on. Nat Rev Cancer 4:757-768. doi:10.1038/nrc1452 (Pubitemid 39331148)
158. Yu MY, Tong JH, Chan PK, Lee TL, Chan MW, Chan AW, Lo KW, To KF (2003) Hypermethylation of the tumor suppressor gene RASSFIA and frequent concomitant loss of heterozygosity at 3p21in cervical cancers. Int J Cancer 105:204-209. doi:10.1002/ijc.11051 (Pubitemid 36505322)
159. Zambrano P, Segura-Pacheco B, Pérez-Cárdenas E, Cetina L, Revilla-Vázquez A, Taja-Chayeb L, Chávez-Blanco A, Angeles E, Cabrera G, Sandoval K, Trejo-Becerril C, Chanona-Vilchis J, Dueńas- González A (2005) A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes. BMC Cancer 5:44. doi:10.1186/1471-2407-5-44 (Pubitemid 41461085)
160. Zhang B, Laribee RN, Klemsz MJ, Roman A (2004) Human papillomavirus type 16 E7 protein increases acetylation of histone H3 in human foreskin keratinocytes. Virology 329 (1):189-198. doi:10.1016/j.virol.2004.08.009 (Pubitemid 39346040)
161. Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6(7):730-755
162. Zheng DL, Zhang L, Cheng N, Xu X, Deng Q, Teng XM, Wang KS, Zhang X, Huang J, Han ZG (2009) Epigenetic modification induced by hepatitis B virus X protein via interaction with de novo DNA methyltransferase DNMT3A. J Hepatol 50:377-387. doi:10.1016/j.jhep.2008.10.019
163. Zimmermann H, Degenkolbe R, Bernard HU, O'Connor MJ (1999) The human papillomavirus type 16 E6 oncoprotein can downregulate p53 activity by targeting the transcriptional coactivator CBP/p300. J Virol 73(8):6209-6219 (Pubitemid 29327795)
164. zur Hausen H (2006) Infections causing human cancer. Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany
165. zur Hausen H (2008) Novel human polyomaviruses-re-emergence of a well known virus family as possible human carcinogens. Int J Cancer 123:247-250. doi:10.1002/ijc.23620 (Pubitemid 351842006)
166. zur Hausen H (2009) Papillomaviruses in the causation of human cancers-a brief historical account. Virology 384(2):260-265. doi:10.1016/j.virol.2008.11. 046